Surface Oncology DSO Ratio 2011-2026 | SURF

Annual DSO Ratio Surface Oncology

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	7.98	1.98	-	-	-	-	-	-	-

All numbers in USD currency

Maximum	Minimum	Average
7.98	1.98	4.98

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Alterity Therapeutics Limited ATHE	16.2 K	$ 3.97	6.43 %	$ 9.55 B	Australia
Adverum Biotechnologies ADVM	222	-	-	$ 86.2 M	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Alnylam Pharmaceuticals ALNY	58.1	$ 320.13	-3.98 %	$ 41.9 B	USA
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
Amphastar Pharmaceuticals AMPH	70.9	$ 21.81	0.6 %	$ 1.02 B	USA
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	16.8	-	-13.39 %	$ 1.45 M	USA
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
Can-Fite BioPharma Ltd. CANF	28.1	$ 3.08	-4.94 %	$ 5.07 M	Israel
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	62.9	$ 1.35	-12.9 %	$ 347 M	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
Aquestive Therapeutics AQST	103	$ 4.26	0.47 %	$ 456 M	USA
Arcutis Biotherapeutics ARQT	106	$ 24.19	-1.59 %	$ 3.08 B	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
BioDelivery Sciences International BDSI	115	-	-4.8 %	$ 255 M	USA
Autolus Therapeutics plc AUTL	58.2	$ 1.61	8.05 %	$ 428 M	Britain
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	2.47	-	-	$ 546 M	USA
CureVac N.V. CVAC	13.6	-	-	$ 867 M	Germany
Cidara Therapeutics CDTX	2.26 K	-	-	$ 1.41 B	USA
BioXcel Therapeutics BTAI	103	$ 1.07	1.9 %	$ 13.1 M	USA
CymaBay Therapeutics CBAY	182	-	-	$ 3.45 B	USA
ChromaDex Corporation CDXC	24.7	-	-0.88 %	$ 598 M	USA